Want to see FR:RBT full AI Analyst Report?
Top Page
Robertet
(RBT)
Select Model
Select Model
Rating:67Neutral
Price Target:
€829.00
▲(3.88% Upside)
Action:Reiterated
Date:09/23/26
The score is driven mainly by solid financial performance (strong revenue/profitability with manageable leverage), supported by reasonable valuation and a constructive earnings outlook. These positives are tempered by weak technicals (price below key moving averages and negative MACD) and cash-flow quality considerations (moderate conversion and volatility), which meaningfully limit the overall score.
Positive Factors
Diversified growth in Fragrance and Health & Beauty
Strong Fragrance growth, supported by premiumization and international demand, indicates durable brand and creative capabilities. Together with Health and Beauty expansion, it diversifies revenue across attractive applications and reduces reliance on any single market over the coming quarters.
Negative Factors
Weakness in Raw Materials demand
The Raw Materials decline shows that a previously strong business area is exposed to tougher market conditions and difficult comparisons. Prolonged weakness would weigh on consolidated growth and could reduce operating leverage, particularly if customers remain cautious across ingredient categories.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified growth in Fragrance and Health & Beauty
Strong Fragrance growth, supported by premiumization and international demand, indicates durable brand and creative capabilities. Together with Health and Beauty expansion, it diversifies revenue across attractive applications and reduces reliance on any single market over the coming quarters.
Read all positive factors
Robertet (RBT) vs. iShares MSCI France ETF (EWQ)
Market Cap
€1.57B
Dividend Yield1.51%
Average Volume (3M)1.07K
Price to Earnings (P/E)16.0
Beta (1Y)0.40
Revenue Growth0.30%
EPS Growth0.78%
CountryFR
Employees2,570
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)49.58
Shares Outstanding2,046,518
10 Day Avg. Volume661
30 Day Avg. Volume1,070
Financial Highlights & Ratios
PEG Ratio1.71
Price to Book (P/B)3.16
Price to Sales (P/S)2.26
P/FCF Ratio28.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1,015.00Price Target Upside27.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)45.27
Revenue Forecast (FY)€863.80M
Robertet Business Overview & Revenue Model
Company Description
Robertet SA specializes in the creation and distribution of fragrances, flavorings, and a diverse range of natural products. Its operations are strategically divided into three principal divisions: Raw Materials, Fragrances, and Flavors. The compa...
How the Company Makes Money
Robertet makes money primarily by selling (1) formulated flavor and fragrance compositions and (2) natural raw materials and extracts to industrial customers. Revenue is generated through business-to-business contracts where Robertet supplies eith...
Robertet Earnings Call Summary
Earnings Call Date:Sep 17, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Apr 21, 2027
Earnings Call Sentiment Positive
The call was broadly constructive. Robertet delivered positive organic growth, strong Fragrance and Health and Beauty performance, resilient profitability, improved operating cash flow, positive free cash flow, sustainability leadership, and continued investment in future growth. These positives were partly offset by a 0.5% reported revenue decline, weaker Raw Materials and Flavors performance, lower EBITDA versus an exceptionally strong prior-year period, oil-linked cost pressure, a lower-end full-year growth outlook, and currently unsuccessful M&A efforts.Positive Updates
Positive Organic Growth Despite Currency Headwinds
First-half organic growth reached 2.8% despite a moderate market environment, adverse currency effects, and contrasting divisional trends. Reported revenue was EUR 444 million, while currency effects reduced reported growth by 3 percentage points, mainly due to the strengthening euro.
Negative Updates
Reported Revenue Decline
First-half revenue declined slightly by 0.5% to EUR 444 million, compared with a very strong first half of 2025. The second quarter's organic growth was 0.7%, down from 4.9% in the first quarter as the market environment became more moderate.
Read all updates
Q2-2026 Updates
Positive
Negative
Positive Organic Growth Despite Currency Headwinds
First-half organic growth reached 2.8% despite a moderate market environment, adverse currency effects, and contrasting divisional trends. Reported revenue was EUR 444 million, while currency effects reduced reported growth by 3 percentage points, mainly due to the strengthening euro.
Read all positive updates
Company Guidance
For 2026, Robertet is targeting organic growth of between +3% and +5% for the full-year, with the year to go expected to be between +4.7% and +7%; it expects resilient profitability, with an EBITDA above 21%, and said the second half will be a bit more pricing driven than volume driven, with easier comparatives and a strong baseline. The company is targeting an EBITDA in line with the past three years, while its long-term guidance remains above 20%; CapEx is expected to remain between 4% and 5% of sales. By 2030, Robertet wants to reach between EUR 1.1 billion and EUR 1.2 billion, implying an annual average growth of 5%-7% between 2025 and 2030, including EUR 50 million to EUR 80 million of revenues from targeted acquisitions over this period; its M&A sweet spots are companies between EUR 15 million-EUR 50 million sales, and there is no plan of buyback at the end of the year and in the years to come.Robertet Financial Statement Overview
Summary
Income Statement
84
Very Positive
Balance Sheet
72
Positive
Cash Flow
68
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 841.88M | 843.93M | 807.61M | 721.13M | 703.04M | 606.09M |
| Gross Profit | 139.01M | 146.61M | 455.19M | 391.79M | 373.36M | 101.89M |
| EBITDA | 21.35M | 168.21M | 160.03M | 132.89M | 125.61M | 116.20M |
| Net Income | 99.08M | 103.43M | 90.07M | 74.60M | 76.02M | 71.71M |
Balance Sheet | ||||||
| Total Assets | 1.08B | 1.00B | 1.01B | 927.13M | 847.21M | 783.29M |
| Cash, Cash Equivalents and Short-Term Investments | 176.98M | 180.67M | 193.47M | 172.59M | 128.06M | 190.01M |
| Total Debt | 256.71M | 233.33M | 268.00M | 325.63M | 297.87M | 112.73M |
| Total Liabilities | 430.01M | 399.53M | 456.07M | 460.72M | 431.43M | 237.39M |
| Stockholders Equity | 647.10M | 602.50M | 551.80M | 465.51M | 414.99M | 545.73M |
Cash Flow | ||||||
| Free Cash Flow | 72.51M | 67.13M | 73.82M | 84.47M | 24.11M | 64.34M |
| Operating Cash Flow | 117.81M | 110.98M | 112.41M | 101.82M | 46.87M | 85.12M |
| Investing Cash Flow | -76.15M | -65.93M | -38.33M | -81.21M | -67.36M | -45.83M |
| Financing Cash Flow | -60.10M | -58.52M | -58.93M | -2.30M | -43.28M | -4.69M |
Robertet Technical Analysis
Positive
798.00
Price Trends
772.94
Positive
789.13
Positive
802.28
Negative
Market Momentum
6.54
Negative
65.61
Neutral
83.48
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:RBT, the sentiment is Positive. The current price of 798 is above the 20-day moving average (MA) of 773.40, above the 50-day MA of 772.94, and below the 200-day MA of 802.28, indicating a neutral trend. The MACD of 6.54 indicates Negative momentum. The RSI at 65.61 is Neutral, neither overbought nor oversold. The STOCH value of 83.48 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:RBT.
Robertet Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | €3.04B | 25.26 | 16.52% | 2.75% | -4.21% | -15.38% | |
67 Neutral | €1.57B | 16.03 | 15.86% | 1.51% | 0.30% | 0.78% | |
66 Neutral | €554.10M | 21.05 | 8.55% | 3.96% | -9.73% | -9.08% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | €74.86M | 45.33 | 3.51% | 1.47% | 6.97% | -73.50% |
* General Sector Average
FR:RBT
Robertet
795.00
-25.75
-3.14%
FR:ITP
Interparfums
34.60
8.67
33.42%
FR:SBT
Oeneo SA
8.84
-0.05
-0.52%
FR:ALBKK
Baikowski SA
20.40
-3.11
-13.24%
Robertet Corporate Events
Robertet Posts Resilient First-Half 2026 Results and Confirms Growth Targets
Sep 17, 2026
Robertet reported first-half 2026 consolidated revenue of €444 million, reflecting organic growth of 2.8% at constant exchange rates but a slight overall decline due to currency and scope effects. Profitability remained strong, with current ...
Robertet Updates Share Capital and Voting Rights Structure
Sep 1, 2026
Robertet SA has reported its updated share capital structure as of August 31, 2026, with a total of 2,169,297 shares outstanding and 3,027,825 theoretical voting rights. After accounting for 71,313 shares without voting rights, the company confirm...
Robertet Updates Share Capital and Voting Rights Structure
Aug 4, 2026
Robertet SA has disclosed updated information on its share capital and voting rights as of July 31, 2026, in line with French Commercial Code and AMF regulatory requirements. The company reports a total of 2,169,297 shares in issue, corresponding ...
Robertet Posts Modest Organic Growth Amid Currency Headwinds in First Half 2026
Jul 23, 2026
Robertet, a global leader in natural raw materials for fragrances, flavors and beauty ingredients, reported consolidated first-half 2026 revenue of €444 million, slightly down 0.5% from 2025 due mainly to adverse currency and scope effects. ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.